New once-nightly pill may ease narcolepsy symptoms in kids
NCT ID NCT06809803
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new extended-release version of sodium oxybate taken as a single dose at bedtime for children with narcolepsy type 1. Researchers want to see if kids prefer it over current twice-nightly options and if it is safe and convenient. About 36 children from Stanford Sleep Clinic will take part.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NARCOLEPSY TYPE 1 (NT 1) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Stanford University
RECRUITINGRedwood City, California, 94063, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.